Department of Medicine 5 – Haematology and Oncology

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia (2021) Stasik S, Eckardt JN, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, et al. Journal article Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population (2021) Lorch M, Pfirrmann M, Fabisch C, Oberle L, Kohn D, Kohlbrenner K, Bruemmendorf TH, et al. Conference contribution The CAR-HEMATOTOX model identifies patients with a high risk for CAR T-cell related hematotoxicity and is associated with prolonged hospitalization and poor prognosis (2021) Rejeski K, Perez A, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, et al. Conference contribution Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma (2021) Rejeski K, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, Bucklein , et al. Conference contribution Knowledge transfer to enhance the performance of deep learning models for automated classification of B-cell neoplasms (2021) Mallesh N, Zhao M, Meintker L, Hoellein A, Elsner F, Lueling H, Haferlach T, et al. Conference contribution Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, Büttner-Herold M, et al. Conference contribution CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity (2021) Stoll A, Bruns H, Gamali S, Saul D, Fuchs M, Nimmerjahn F, Kunz M, et al. Conference contribution How does phagocytosis affect macrophages? (2021) Biedermann A, Flamann C, Mougiakakos D, Bitterer K, Leffler M, Kellner C, Peipp M, et al. Conference contribution A20 as a novel prognostic factor for recurrence and patients' survival in oral squamous cell carcinoma (2021) Spörl S, Erber R, Gerken M, Fischer R, Taxis J, Meier JK, Geppert CI, et al. Conference contribution Effect of Idelalisib on PKC beta/NF-kappa B regulation in stromal cells of chronic lymphocytic leukemia (2021) Lutzny-Geier G, Handl SA, Von Heydebrand F, Wilke J, Kremer AL, Mackensen A, Völkl S Conference contribution